Bone Healing and Failure - Engineered Bone: Tissue Engineering Intelligence Unit - page 55

References
1. Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J
Orthop Res 1984; 2:97-101.
2. Hiltunen A, Vuorio E, Aro HT. A standardized experimental fracture in the mouse tibia. J Orthop
Res 1993; 11:305-312.
3. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop 1998; 355S:S7-S21.
4. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg 1978; 60-B:150-162.
5. Carter DR, Beaupré GS, Giori NJ et al. Mechanobiology of skeletal regeneration. Clin Orthop
1998; 355S:S41-S55.
6. Brighton CT, Hunt RM. Early histologic and ultrastructural changes in microvessels of periosteal
callus. J Orthop Trauma 1997; 11:244-253.
7. Bolander ME. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 1998;
200:165-170.
8. Barnes GL, Kostenuik PJ, Gerstenfeld LC et al. Perspective: Growth factor regulation of fracture
repair. J Bone Miner Res 1999; 14(11):1805-1815.
9. Einhorn TA, Majeska RJ, Rush EB et al. The expression of cytokine activity by fracture callus. J
Bone Miner Res 1995; 10:1272-1281.
10. Cho T, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the trans-
forming growth factor β superfamily during murine fracture healing. J Bone Miner Res 2002;
17(3):513-520.
11. Kon T, Cho T, Aizawa T et al. Expression of osteoprotegerin, receptor activator of NF- κ B ligand
(osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. Bone Miner
Res 2001; 16(6):1004-1013.
12. Glowacki J. Angiogenesis in fracture repair. Clin Orthop 1998; 355S:S82-S89.
13. Yamada K, Tabata Y, Yamamoto K et al. Potential efficacy of basic fibroblast growth factor incor-
porated in biodegradable hydrogels for skull bone regeneration. J Neurosurg 1997; 86:871-875.
14. Longaker MT, Moelleken BR, Cheng JC et al. Fetal fracture healing in a lamb model. Plast Reconstr
Surg 1992; 90:161-171.
15. Wang JS, Aspenberg P. Basic fibroblast growth factor promotes bone ingrowth in porous hy-
droxyapatite. Clin Orthop 1996; 333:252-260.
16. Wang JS. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or
conductive implants. Acta Orthop Scand 1996; 269(Suppl):1-33.
17. Chang HN, Garetto LP, Potter RH et al. Angiogenesis and osteogenesis in an orthopedically ex-
panded suture. Am J Orthod Dentofacial Orthop 1997; 111:382-390.
18. Harada S, Rodan SB, Rodan GA. Expression and regulation of vascular endothelial growth factor
in osteoblasts. Clin Orthop 1995; 313:76-80.
19. Goad DL, Rubin J, Wang H et al. Enhanced expression of vascular endothelial growth factor in
human Sa-OS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor
I. Endocrinology 1996; 137:2262-2268.
20. Deckers MM, van Bezooijen RJ, van der Horst G et al. Bone morphogenetic proteins stimulate
angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;
143(4):1545-1553.
21. Ozaki H, Hayashi H, Vinores SA et al. Intravital sustained release of VEGF causes retinal
neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.
Exp Eye Res 1997; 64:505-517.
22. Mulhauser J, Merril MJ, Pili R et al. VEGF165 expressed by a replication-deficient recombinant
adenovirus vector induces angiogenesis in vivo. Circ Res 1995; 77:1077-1086.
23. Tsurumi Y, Takeshita S, Cheu D et al. Direct intramuscular gene transfer of naked DNA encod-
ing vascular endothelial growth factor augments collateral development and tissue perfusion. Circu-
lation 1996; 94:3281-3290.
24. Gowen M, Wood DD, Ihrie EJ et al. An interleukin 1-like factor stimulates bone resorption in
vitro. Nature 1993; 306:378.
25. Skjodt H, Russell G. Bone cell biology and the regulation of bone metabolism. In: Gown M, ed.
Cytokines and Bone Metabolism. FL, USA: CRC Press, 1992:1-70.
26. Dinarello CA, Mier JW. Lymphokines. N Engl J Med 1987; 317:940-945.
27. Kimble RB, Vannice JL, Bloedow DC et al. Interleukin-1 receptor antagonist decreases bone loss
and bone resorption in ovariectomized rats. J Clin Invest 1994; 93:1959-1967.
28. Stashenko P, Dewhirst FE, Peros WJ et al. Synergistic interaction between IL-1, tumor necrosis
factor, and lymphotoxin in bone resorption. J Immunol 1987; 138:1464-1468.